Total Cost of Care Reduction in IDA Patients With Ferric Carboxymaltose

By pressing "continue", I attest that I am affiliated with at least one of the following organizations: public or private sector payors, formulary committees (e.g., pharmacy and therapeutics committees), drug information centers, technology assessment committees, pharmacy benefit managers/management organizations, third party administrators, and any other multidisciplinary entities that, on behalf of health care organizations, I am currently carrying out my professional responsibilities to review scientific and/or technology assessments to make drug or device selection or acquisition, formulary management, and/or coverage and reimbursement decisions on a population basis.